-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Amphastar Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2012 to Q1 2025.
- Amphastar Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2025 was $7.37M, a 8.11% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. annual Depreciation for 2024 was $28.2M, a 12.1% increase from 2023.
- Amphastar Pharmaceuticals, Inc. annual Depreciation for 2023 was $25.2M, a 5.84% increase from 2022.
- Amphastar Pharmaceuticals, Inc. annual Depreciation for 2022 was $23.8M, a 7.29% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)